NCT05734716View on ClinicalTrials.gov

Colorado-Oregon Altitude Study

PHASE4CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

February 17, 2021

Primary Completion Date

August 1, 2022

Study Completion Date

January 1, 2023

Conditions
Acute Mountain Sickness
Interventions
DRUG

Erythropoietin

use of erythropoietin to stimulate red blood cell development prior to ascent to altitude

DRUG

Iron sucrose (Venofer)

use of iron sucrose to stimulate red blood cell development prior to ascent to altitude

DRUG

Sterile Sodium Chloride

sham treatment with sterile saline

Trial Locations (2)

80461

Colorado Mountain College, Leadville

97403

Cardiopulmonary and Respiratory Physiology Lab, Eugene

All Listed Sponsors
lead

University of Oregon

OTHER

NCT05734716 - Colorado-Oregon Altitude Study | Biotech Hunter | Biotech Hunter